TAT1 inhibitors belong to a distinctive chemical class that primarily targets tubulin acetyltransferase 1, a key enzyme involved in the post-translational modification of microtubules within cellular structures. Microtubules, composed of tubulin protein subunits, play pivotal roles in maintaining cell shape, intracellular transport, and cell division. TAT1, the enzyme responsible for acetylating alpha-tubulin, participates in the dynamic regulation of microtubule stability and function. The inhibition of TAT1 alters the acetylation pattern of alpha-tubulin, influencing microtubule dynamics and cellular processes dependent on microtubule integrity.
TAT1 inhibitors often exhibit a distinct arrangement of functional groups that interact with specific binding sites on the TAT1 enzyme, disrupting its catalytic activity. The chemical design of TAT1 inhibitors takes into account the intricate molecular interactions between the inhibitor and the enzyme's active sites, aiming to selectively modulate TAT1 without affecting other cellular components. By impeding tubulin acetylation through TAT1 inhibition, these compounds have the potential to perturb cellular functions that rely on properly regulated microtubule dynamics, providing researchers with valuable tools to investigate the physiological consequences of altered tubulin acetylation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gabaculine | 59556-17-1 | sc-200473 sc-200473A sc-200473B | 10 mg 50 mg 250 mg | $347.00 $867.00 $3009.00 | 5 | |
Inhibits GABA transaminases, structurally similar to the substrate of TAT1, so may bind to and inhibit TAT1. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Inhibits dihydrofolate reductase, could lead to accumulation of metabolites that indirectly inhibit TAT1. | ||||||
Methylene blue | 61-73-4 | sc-215381B sc-215381 sc-215381A | 25 g 100 g 500 g | $42.00 $102.00 $322.00 | 3 | |
A redox cycling agent, can modulate cellular redox states that might affect TAT1 activity. | ||||||
4-Phosphonomethylphenylalanine | 142434-81-9 | sc-397456 sc-397456A | 100 mg 1 g | $326.00 $3193.00 | ||
A phenylalanine derivative that can act as a tyrosine analogue, potentially inhibiting TAT1. | ||||||
Hydroxylamine hydrochloride | 5470-11-1 | sc-211616 sc-211616A | 25 g 100 g | $50.00 $64.00 | 1 | |
General aminotransferase inhibitor, could inhibit TAT1 through covalent modification of the active site. | ||||||